个人简介

    潘校琦，医学博士，中药学博士后，副教授，预防医学教研室主任，英国牛津大学访问学者，四川省中医药管理局学术技术带头人后备人选，中国毒理学会毒理学教育专委会青年委员，四川省科技青年联合会理事。主要致力于食品中丙烯酰胺与晚期糖基化终末产物（AGEs）的神经毒性作用机制，以及有毒中药的毒效作用关系与分子机制研究。主持国家自然科学基金青年基金、四川省自然科学基金、中国博士后科学基金各1项，“杏林学者”学科人才科研提升计划项目4项；主研国家自然科学基金重大项目子课题、面上项目、青年项目各3项，四川省科技厅项目4项；发表国内外期刊论文30篇，其中作为第一作者或通讯作者SCI论文20篇（IF≥5.0论文8篇），国际国内学术会议交流与报告多次；主持教育部产学合作协同育人项目1项，校级教学改革项目2项；省级课程思政示范课程负责人，学校教学成果特等奖，学校年度人物提名，编写国家级规划教材三部。

代表性成果

[1] Li Qiuju, Peng Fu, Yan Xiaoyu, Chen Yan, Zhou Jie, Wu Shuangyue, Jiang Wanyanhan, Jin Xuhui, Liang Jie, Peng Cheng^#, Pan Xiaoqi^#. Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro. Journal of Ethnopharmacology, 2023, 303:116029.（IF: 5.195）

[2] Zhou Jie, Peng Cheng, Li Qiuju, Yan Xiaoyu, Yang Liang, Li Mengting, Cao Xiaoyu, Xie Xiaofang, Chen Dayi, Rao Chaolong, Huang Sizhou, Peng Fu^#, Pan Xiaoqi^#. Dopamine homeostasis imbalance and dopamine receptors-mediated AC/cAMP/PKA pathway activation are involved in aconitine-induced neurological impairment in zebrafish and SH-SY5Y cells. Frontiers in Pharmacology. 2022, 13: 837810.（IF: 5.988）

[3] Li Qiuju, Yan Xiaoyu, Zhang Ying, Zhou Jie, Yang Liang, Wu Shuangyue, Peng Cheng^#, Pan Xiaoqi^#. Risk compounds, potential mechanisms and biomarkers of traditional Chinese medicine-induced reproductive toxicity. Journal of Applied Toxicology. 2022, 1-23. （IF: 3.628）

[4] Wang Wenlin, Jiang Jialuo, Huang Yan, Peng Fu, Hu Tingting, Wu Jiayang, Pan Xiaoqi^#, Rao Chaolong^#. Aconitine induces autophagy via activating oxidative DNA damage-mediated AMPK/ULK1 signaling pathway in H9c2 cells. Journal of Ethnopharmacology. 2022, 282: 114631. （IF: 5.195）

[5] Yang Liang, Chen Yan, Zhou Jie, Sun Jiayi, Jiang Wanyanhan, Liu Tianyu, Rao Chaolong^#, Pan Xiaoqi^#. Aconitine induces mitochondrial energy metabolism dysfunction through inhibition of AMPK signaling and interference with mitochondrial dynamics in SH-SY5Y cells. Toxicology Letters. 2021, 347: 36-44. （IF: 4.271）

[6] Zhou Jie, Peng Fu, Cao Xiaoyu, Xie Xiaofang, Chen Dayi, Yang Liang, Rao Chaolong, Peng Cheng^#, Pan Xiaoqi^#. Risk compounds, preclinical toxicity evaluation, and potential mechanisms of Chinese mteria medica-induced cardiotoxicity. Frontiers in Pharmacology. 2021, 12: 578796. （IF: 5.988）

[7] Peng Fu, Fan Huali, Li Sui, Peng Cheng^#, Pan Xiaoqi^#. MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy. International Journal of Molecular Sciences. 2021, 22(14):7526. （IF: 6.208）

[8] Pan Xiaoqi, Zhou Jie, Chen Yan, Xie Xiaofang, Rao Chaolong, Liang Jie, Zhang Ying, Peng Cheng^#. Classification, hepatotoxic mechanisms, and targets of the risk ingredients in traditional Chinese medicine-induced liver injury. Toxicology Letters. 2020, 323: 48-56. （IF: 4.271）

[9] Pan Xiaoqi, Dong Lan, Yang Lian, Chen Dayi, Peng Cheng^#. Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. Virus Research. 2020, 286:198057. （IF: 6.286）

[10] Pan Xiaoqi, Ma Xiao, Jiang Yinxiao, Wen Jianxia, Yang Lian, Chen Dayi, Cao Xiaoyu, Peng Cheng^#. A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids. Evid Based Complement Alternat Med. 2020: 7171498. （IF: 2.65）